
NHS rolls out fast tracked immunotherapy for advanced endometrial cancer
Immunotherapy dostarlimab (Jemperli) will be available on the NHS for patients with advanced primary or…

Immunotherapy dostarlimab (Jemperli) will be available on the NHS for patients with advanced primary or…

Hundreds of thousands of women in England deemed at increased risk of breast cancer could…

The risk of overdiagnosis among older women who are screened for breast cancer increases significantly…